asx:lct.ax otc:lvcly.pk a personal perspective and a glimpse of the future school of biological...

27
ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf of Living Cell Technologies

Upload: shon-hart

Post on 01-Jan-2016

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

ASX:LCT.AX OTC:LVCLY.PK

A personal perspective and a glimpse of the future

School of Biological Sciences, 11 March 2011

Professor R. B. Elliott on behalf of Living Cell Technologies

Page 2: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

The Story begins - 1961

George Maxwell

Page 3: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Paul Lacey

Page 4: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

1961

Transplant new cells from rats into anterior eye chamber of the eye of diabetic rabbits---failed.

Transplant rat islets inserted into a semi permeable chamber inserted under the skin of diabetic rabbits----- failed

Page 5: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

1976

Transplant human foetal islets

intramuscularly into Type 1 diabetic

humans------ failed

Page 6: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

1995

Transplant newborn pig islets into peritoneal cavity of humans with T1D failed

David Collinson

Page 7: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

1996

Transplant newborn pig islets

encapsulated into semi-permeable

microcapsules

Page 8: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Michael Helyer - 1996

Page 9: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Michael Helyer - 2005

Page 10: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

1996 – 2007

Virtual moratorium PERV

Page 11: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Auckland Islands

Auckland Islands, New Zealand.

• Unique source . NO xeno-relevant viruses, bacteria and parasites.

NULL PIGS (PERV).• Herd now bred in documented bio-isolation.

• Three year health records and regular monitoring. Three generations without mammalian content in feed.

• Health Monitoring. Regular testing by IANZ accredited laboratory for all of herd and all donors.

Page 12: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Facilities

Page 13: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Encapsulated Islet

Page 14: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Russian Patient Video

Page 15: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Dr. Paul Tan

Page 16: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

NZ Study - Patient # 1 Result

-8 -6 -4 -2 0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40 42 44 46 48 50 520

1

2

3

4

5

6

7

Patient #1: Asymptomatic Hypos

Week Number

Num

ber o

f Asy

mpt

omati

c Hyp

os

Page 17: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Choroid Plexus

Page 18: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Choroid Plexus

Page 19: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf
Page 20: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Dopamine containing cells

Page 21: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Monkey Study Results

Page 22: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Other Projects

• Restoring auditory nerves

• Liver cells for haemophilia

Page 23: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Other studies under way

• Regeneration of auditory spiral ganglion cells

• Human cells for replacement of the clotting factor V111, haemophilia

Page 24: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

For future other possibilities

Providing biologics in excess to treat non-deficiencydiseases

Cells over expressing therapeutics

E.g. localised delivery of TNF for cancer treatmentIntestinal L cells for obesity

Page 25: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

Living cell treatment is an exciting new frontier, which

skilled biologists need to explore.

The rewards are likely to be high.

Page 26: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf
Page 27: ASX:LCT.AX OTC:LVCLY.PK A personal perspective and a glimpse of the future School of Biological Sciences, 11 March 2011 Professor R. B. Elliott on behalf

There is nothing more difficult to take in hand, more perilous to conduct, or more uncertain in its success, than to take the lead in the introduction of a

new order of things.

Niccolo Machiavelli